Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Evidence for a role for alpha6( *) nAChRs in l-dopa-induced dyskinesias using Parkinsonian alpha6( *) nAChR gain-of-function mice - Bordia_2015_Neurosci_295_187 |
| Author(s) : Bordia T , McGregor M , McIntosh JM , Drenan RM , Quik M |
| Ref : Neuroscience , 295 :187 , 2015 |
| Abstract : Bordia_2015_Neurosci_295_187 |
| ESTHER : Bordia_2015_Neurosci_295_187 |
| PubMedSearch : Bordia_2015_Neurosci_295_187 |
| PubMedID: 25813704 |
| Title : The alpha7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions - Bordia_2015_Exp.Neurol_263_277 |
| Author(s) : Bordia T , McGregor M , Papke RL , Decker MW , McIntosh JM , Quik M |
| Ref : Experimental Neurology , 263 :277 , 2015 |
| Abstract : Bordia_2015_Exp.Neurol_263_277 |
| ESTHER : Bordia_2015_Exp.Neurol_263_277 |
| PubMedSearch : Bordia_2015_Exp.Neurol_263_277 |
| PubMedID: 25261754 |
| Title : Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease - Quik_2015_Biochem.Pharmacol_97(4)_399 |
| Author(s) : Quik M , Zhang D , McGregor M , Bordia T |
| Ref : Biochemical Pharmacology , 97 :399 , 2015 |
| Abstract : Quik_2015_Biochem.Pharmacol_97(4)_399 |
| ESTHER : Quik_2015_Biochem.Pharmacol_97(4)_399 |
| PubMedSearch : Quik_2015_Biochem.Pharmacol_97(4)_399 |
| PubMedID: 26093062 |
| Title : Poster: Striatal cholinergic interneurons regulate L-dopa-induced dyskinesias - |
| Author(s) : Bordia T , Xiomara Perez XA , Zhang D , Quik M |
| Ref : Biochemical Pharmacology , 97 :630 , 2015 |
| PubMedID: |
| Title : ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease - Zhang_2014_Mov.Disord_29_508 |
| Author(s) : Zhang D , Bordia T , McGregor M , McIntosh JM , Decker MW , Quik M |
| Ref : Movement Disorders , 29 :508 , 2014 |
| Abstract : Zhang_2014_Mov.Disord_29_508 |
| ESTHER : Zhang_2014_Mov.Disord_29_508 |
| PubMedSearch : Zhang_2014_Mov.Disord_29_508 |
| PubMedID: 24515328 |
| Title : Role for the nicotinic cholinergic system in movement disorders\; therapeutic implications - Quik_2014_Pharmacol.Ther_144_50 |
| Author(s) : Quik M , Zhang D , Perez XA , Bordia T |
| Ref : Pharmacol Ther , 144 :50 , 2014 |
| Abstract : Quik_2014_Pharmacol.Ther_144_50 |
| ESTHER : Quik_2014_Pharmacol.Ther_144_50 |
| PubMedSearch : Quik_2014_Pharmacol.Ther_144_50 |
| PubMedID: 24836728 |
| Title : Alpha4beta2 nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats - Quik_2013_Neuropharmacol_71_191 |
| Author(s) : Quik M , Campos C , Bordia T , Strachan JP , Zhang J , McIntosh JM , Letchworth SR , Jordan K |
| Ref : Neuropharmacology , 71 :191 , 2013 |
| Abstract : Quik_2013_Neuropharmacol_71_191 |
| ESTHER : Quik_2013_Neuropharmacol_71_191 |
| PubMedSearch : Quik_2013_Neuropharmacol_71_191 |
| PubMedID: 23583932 |
| Title : Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function - Quik_2013_Neurobiol.Dis_50_30 |
| Author(s) : Quik M , Mallela A , Chin M , McIntosh JM , Perez XA , Bordia T |
| Ref : Neurobiol Dis , 50 :30 , 2013 |
| Abstract : Quik_2013_Neurobiol.Dis_50_30 |
| ESTHER : Quik_2013_Neurobiol.Dis_50_30 |
| PubMedSearch : Quik_2013_Neurobiol.Dis_50_30 |
| PubMedID: 23009753 |
| Title : The nicotine-mediated decline in l-dopa-induced dyskinesias is associated with a decrease in striatal dopamine release - Bordia_2013_J.Neurochem_125_291 |
| Author(s) : Bordia T , McIntosh JM , Quik M |
| Ref : Journal of Neurochemistry , :291 , 2013 |
| Abstract : Bordia_2013_J.Neurochem_125_291 |
| ESTHER : Bordia_2013_J.Neurochem_125_291 |
| PubMedSearch : Bordia_2013_J.Neurochem_125_291 |
| PubMedID: 23373725 |
| Title : Nicotine as a potential neuroprotective agent for Parkinson's disease - Quik_2012_Mov.Disord_27_947 |
| Author(s) : Quik M , Perez XA , Bordia T |
| Ref : Movement Disorders , 27 :947 , 2012 |
| Abstract : Quik_2012_Mov.Disord_27_947 |
| ESTHER : Quik_2012_Mov.Disord_27_947 |
| PubMedSearch : Quik_2012_Mov.Disord_27_947 |
| PubMedID: 22693036 |
| Title : Varenicline is a potent partial agonist at alpha6beta2* nicotinic acetylcholine receptors in rat and monkey striatum - Bordia_2012_J.Pharmacol.Exp.Ther_342_327 |
| Author(s) : Bordia T , Hrachova M , Chin M , McIntosh JM , Quik M |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 342 :327 , 2012 |
| Abstract : Bordia_2012_J.Pharmacol.Exp.Ther_342_327 |
| ESTHER : Bordia_2012_J.Pharmacol.Exp.Ther_342_327 |
| PubMedSearch : Bordia_2012_J.Pharmacol.Exp.Ther_342_327 |
| PubMedID: 22550286 |
| Title : Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats - Bordia_2012_J.Pharmacol.Exp.Ther_340_612 |
| Author(s) : Bordia T , McIntosh JM , Quik M |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 340 :612 , 2012 |
| Abstract : Bordia_2012_J.Pharmacol.Exp.Ther_340_612 |
| ESTHER : Bordia_2012_J.Pharmacol.Exp.Ther_340_612 |
| PubMedSearch : Bordia_2012_J.Pharmacol.Exp.Ther_340_612 |
| PubMedID: 22144565 |
| Title : Targeting nicotinic receptors for Parkinson's disease therapy - Quik_2011_CNS.Neurol.Disord.Drug.Targets_10_651 |
| Author(s) : Quik M , Bordia T , Huang L , Perez XA |
| Ref : CNS Neurol Disord Drug Targets , 10 :651 , 2011 |
| Abstract : Quik_2011_CNS.Neurol.Disord.Drug.Targets_10_651 |
| ESTHER : Quik_2011_CNS.Neurol.Disord.Drug.Targets_10_651 |
| PubMedSearch : Quik_2011_CNS.Neurol.Disord.Drug.Targets_10_651 |
| PubMedID: 21838678 |
| Title : alpha6ss2* and alpha4ss2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease - Perez_2010_Mol.Pharmacol_78_971 |
| Author(s) : Perez XA , Bordia T , McIntosh JM , Quik M |
| Ref : Molecular Pharmacology , 78 :971 , 2010 |
| Abstract : Perez_2010_Mol.Pharmacol_78_971 |
| ESTHER : Perez_2010_Mol.Pharmacol_78_971 |
| PubMedSearch : Perez_2010_Mol.Pharmacol_78_971 |
| PubMedID: 20732972 |
| Title : Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization - Bordia_2010_J.Pharmacol.Exp.Ther_333_929 |
| Author(s) : Bordia T , Campos C , McIntosh JM , Quik M |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 333 :929 , 2010 |
| Abstract : Bordia_2010_J.Pharmacol.Exp.Ther_333_929 |
| ESTHER : Bordia_2010_J.Pharmacol.Exp.Ther_333_929 |
| PubMedSearch : Bordia_2010_J.Pharmacol.Exp.Ther_333_929 |
| PubMedID: 20200117 |
| Title : Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys - Huang_2009_J.Neurochem_109_826 |
| Author(s) : Huang LZ , Parameswaran N , Bordia T , McIntosh JM , Quik M |
| Ref : Journal of Neurochemistry , 109 :826 , 2009 |
| Abstract : Huang_2009_J.Neurochem_109_826 |
| ESTHER : Huang_2009_J.Neurochem_109_826 |
| PubMedSearch : Huang_2009_J.Neurochem_109_826 |
| PubMedID: 19250334 |
| Title : Multiple roles for nicotine in Parkinson's disease - Quik_2009_Biochem.Pharmacol_78(7)_677 |
| Author(s) : Quik M , Huang LZ , Parameswaran N , Bordia T , Campos C , Perez XA |
| Ref : Biochemical Pharmacology , 78 :677 , 2009 |
| Abstract : Quik_2009_Biochem.Pharmacol_78(7)_677 |
| ESTHER : Quik_2009_Biochem.Pharmacol_78(7)_677 |
| PubMedSearch : Quik_2009_Biochem.Pharmacol_78(7)_677 |
| PubMedID: 19433069 |
| Title : Nicotinic receptors as CNS targets for Parkinson's disease - Quik_2007_Biochem.Pharmacol_74(8)_1224 |
| Author(s) : Quik M , Bordia T , O'Leary K |
| Ref : Biochemical Pharmacology , 74 :1224 , 2007 |
| Abstract : Quik_2007_Biochem.Pharmacol_74(8)_1224 |
| ESTHER : Quik_2007_Biochem.Pharmacol_74(8)_1224 |
| PubMedSearch : Quik_2007_Biochem.Pharmacol_74(8)_1224 |
| PubMedID: 17631864 |
| Title : Nigrostriatal damage preferentially decreases a subpopulation of alpha6beta2* nAChRs in mouse, monkey, and Parkinson's disease striatum - Bordia_2007_Mol.Pharmacol_72_52 |
| Author(s) : Bordia T , Grady SR , McIntosh JM , Quik M |
| Ref : Molecular Pharmacology , 72 :52 , 2007 |
| Abstract : Bordia_2007_Mol.Pharmacol_72_52 |
| ESTHER : Bordia_2007_Mol.Pharmacol_72_52 |
| PubMedSearch : Bordia_2007_Mol.Pharmacol_72_52 |
| PubMedID: 17409284 |
| Title : Increases in alpha4* but not alpha3*\/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment - McCallum_2006_J.Neurochem_96_1028 |
| Author(s) : McCallum SE , Parameswaran N , Bordia T , Fan H , Tyndale RF , Langston JW , McIntosh JM , Quik M |
| Ref : Journal of Neurochemistry , 96 :1028 , 2006 |
| Abstract : McCallum_2006_J.Neurochem_96_1028 |
| ESTHER : McCallum_2006_J.Neurochem_96_1028 |
| PubMedSearch : McCallum_2006_J.Neurochem_96_1028 |
| PubMedID: 16412091 |
| Title : Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates - Quik_2006_J.Neurochem_98_1866 |
| Author(s) : Quik M , Parameswaran N , McCallum SE , Bordia T , Bao S , McCormack A , Kim A , Tyndale RF , Langston JW , Di Monte DA |
| Ref : Journal of Neurochemistry , 98 :1866 , 2006 |
| Abstract : Quik_2006_J.Neurochem_98_1866 |
| ESTHER : Quik_2006_J.Neurochem_98_1866 |
| PubMedSearch : Quik_2006_J.Neurochem_98_1866 |
| PubMedID: 16882311 |
| Title : Decrease in alpha3*\/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage - McCallum_2005_Mol.Pharmacol_68_737 |
| Author(s) : McCallum SE , Parameswaran N , Bordia T , McIntosh JM , Grady SR , Quik M |
| Ref : Molecular Pharmacology , 68 :737 , 2005 |
| Abstract : McCallum_2005_Mol.Pharmacol_68_737 |
| ESTHER : McCallum_2005_Mol.Pharmacol_68_737 |
| PubMedSearch : McCallum_2005_Mol.Pharmacol_68_737 |
| PubMedID: 15933214 |
| Title : Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA - Quik_2005_Mol.Pharmacol_67_32 |
| Author(s) : Quik M , Vailati S , Bordia T , Kulak JM , Fan H , McIntosh JM , Clementi F , Gotti C |
| Ref : Molecular Pharmacology , 67 :32 , 2005 |
| Abstract : Quik_2005_Mol.Pharmacol_67_32 |
| ESTHER : Quik_2005_Mol.Pharmacol_67_32 |
| PubMedSearch : Quik_2005_Mol.Pharmacol_67_32 |
| PubMedID: 15470079 |